Skip to content
Open·Ingested today, not yet re-verified. Deadlines can change; confirm on the official page.

6550--PHADIA 250 REAGENT AND CONSUMABLES

VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.246-NETWORK CONTRACTING OFFICE 6 (36C246)

Special Notice · not a solicitation. There is nothing to bid on yet: agencies use this notice type for market research or information. You can respond to get on their radar, but do not budget proposal time for it.
View official posting

Free. Verify your email, then we send one reminder only.

Posted
Aug 31, 2026
Closes
Sep 4, 2026 (in 4 days)

See more open contract opportunities like this

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

At a glance

This is a government contract opportunity posted by VETERANS AFFAIRS, DEPARTMENT OF in the in-vitro diagnostic substance manufacturing category. The deadline is September 4, 2026, 5 days from now.

Classification and identifiers

Industry (NAICS)
In-Vitro Diagnostic Substance Manufacturing (325413)
Product or service (PSC)
In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (6550)
Solicitation number
36C24626Q0972

Who can apply

Location not specified

About this opportunity

The Department of Veterans Affairs, Network Contracting Office (NCO) 6 intends to award a sole source, firm fixed price contract to Fisher Scientific Company LLC (LB), 11450 Compaq Center West Dr St., Houston, TX, 77070 for the Phadia 250 associated reagents and consumables for the Fayetteville VAMC located at 2300 Ramsey Street, Fayetteville, NC, 28301. The Phadia 250 instrument is currently owned by the Fayetteville VAMC and Fisher Scientific Company LLC (LB) a branch Thermo Fisher Scientific (LB) (OEM) is the sole authorized source for the procurement of the Phadia 250 instrument and its associated reagents and consumables. Market research has determined that these items can only be obtained from a single source without an unacceptable duplication of cost or delay in the continuity of p...

Refine this search